Coronavirus (COVID-19): visiting The Royal Marsden suspended

Coronavirus (COVID-19) latest: Visiting The Royal Marsden is still suspended, but we want to reassure our patients, their families and anyone worried about cancer during this difficult time that we are still delivering treatment - the hospital is open. Please see more information here about how we are keeping everyone safe.

Services offered: Commercial Partners

For licensing of new radiotherapeutics, regulatory authorities such as the FDA are increasingly requiring information about the radiation doses delivered. 

 

We can offer a broad range of services to support the development of new radiotherapeutics and multicentre clinical trials. Our support can include:

  • Education and training
  • Standard operating procedures and protocols for multi-centre data acquisition with either gamma cameras PET systems or external whole body monitoring
  • Trial specific anthropomorphic phantoms
  • Site validation
  • Data transfer and archiving
  • Clinical image and data processing
  • Ongoing medical physics advice throughout project
  • Dosimetry calculations
  • Centralised data analysis
  • Generation of reports
  • Regulatory advice
  • Pre-clinical dosimetry and pharmacokinetics

No two treatments are alike and there are a wide range of options and methods available to suit different radiotherapeutics and study needs. 

Get in contact with us here